ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: PO0037

Late Presentations of Secondary Oxalate Nephropathy

Session Information

Category: Trainee Case Report

  • 101 AKI: Epidemiology, Risk Factors, and Prevention


  • Hale, Muna, The University of Oklahoma - Tulsa, Tulsa, Oklahoma, United States
  • Kathuria, Pranay, The University of Oklahoma - Tulsa, Tulsa, Oklahoma, United States

Secondary Oxalate nephropathy is an important differential diagnosis for acute kidney injury (AKI) in chronic malabsorptive disease. Mean presentation is typically within 1-2 years. The following three cases are example of late, abrupt presentations of secondary oxalate nephropathy.

Case Description

Our first case includes a 69-year-old female, with gastric bypass surgery 14 years prior, who presented to emergency room (ER) with AKI. Six months prior her creatinine (Cr) was 1.6 mg/dL, but abruptly increased to 5.99 mg/dL. Serologic work up was negative. Renal biopsy was obtained that revealed deposition of oxalate crystals within renal tubules (Figure 1). Our second case showed a 59-year-old male with history of recurrent pancreatitis due to bulimia that presented to the ER for nausea and vomiting. In the ER, patient had a serum Cr of 5.79 mg/dL. Two months prior, Cr was 1.1 mg/dL. Renal biopsy showed widespread oxalate crystals in the interstitium. The last case was a 48-year-old male with chronic pancreatitis who presented with AKI with suspect acute tubular necrosis. He had been diagnosed with chronic pancreatitis for at least 6 years with Cr 0.9 mg/dL. Patient’s Cr remained at 4.00 mg/dL one month later. Renal biopsy revealed interstitial fibrosis and calcium oxalate crystals.


Secondary oxalate nephropathy is a side effect of malabsorptive gastrointestinal (GI) disorders. According to prior case series, the mean presentation of oxalate nephropathy is 1-2 years. These cases illustrate that secondary oxalate nephropathy can present at a later course with rapid onset. Patients also likely progress to ESRD after diagnosis. A systemic review of 108 cases, with 13 months follow up, showed 55% of patients required hemodialysis. Currently, there is no treatment and lifestyle changes include a low fat, oxalate diet. Secondary oxalate nephropathy should be considered in the differential of all patients with malabsorptive states presenting with AKI.

Figure 1